Renin-Angiotensin-Aldosterone System Polymorphisms and 5-Year Mortality in Survivors of Acute Myocardial Infarction
- 1 January 2014
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 55 (3) , 190-196
Abstract
This study sought to evaluate whether genetic variants in the renin-angiotensin-aldosterone system (RAAS) have an impact on long-term mortality after acute myocardial infarction (AMI) in the percutaneous coronary intervention (PCI) era. We investigated the impacts of individual and combinations of 4 major RAAS genetic variants, angiotensinogen (AGT) T1311C, angiotensin-converting enzyme (ACE) insertion/deletion (I/D), angiotensin 2 type 1 receptor A1166C, and aldosterone synthase T4660C on 5-year mortality in 3149 post-AMI patients using multivariate Cox regression analysis. The predictive accuracy of all possible RAAS genetic combinations was evaluated using Cox regression analysis, and the best combination that affected prognosis was determined based on the minimal Akaike Information Criterion. There were 220 deaths during a median follow-up of 4.9 years. Independent analyses of any single RAAS variant did not show signifi cant impacts on 5-year mortality. However, analyses in combination revealed that absence of both AGT CC genotype and ACE D allele was associated with lower 5-year mortality (log-rank P = 0.005). Patients with at least either of the AGT CC or ACE D allele had increased mortality with adjusted hazard ratios of 2.07 (95% confi dence interval 1.18-3.65, P = 0.012), compared with those with neither the AGT CC nor ACE D allele. Among the 4 RAAS genetic variants examined, a combination of AGT and ACE polymorphisms was associated with 5-year mortality after AMI.Keywords
This publication has 25 references indexed in Scilit:
- Genetic polymorphisms in the renin–angiotensin system: relevance for susceptibility to cardiovascular diseaseEuropean Journal of Pharmacology, 2000
- Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysisJournal of Human Hypertension, 2000
- Angiotensinogen gene and essential hypertension in the JapaneseJournal Of Hypertension, 1999
- Evidence for Association and Genetic Linkage of the Angiotensin-Converting Enzyme Locus With Hypertension and Blood Pressure in Men but Not Women in the Framingham Heart StudyCirculation, 1998
- Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With HypertensionAmerican Journal of Hypertension, 1998
- The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal riskJournal Of Hypertension, 1997
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyNew England Journal of Medicine, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992